Wanli Lin

Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (<scp>NIC‐ESCC2019</scp>): A multicenter, phase 2 study

Jun Liu, Jingpei Li, Wanli Lin et al. · International Journal of Cancer · 2022 · 160 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Conversion Surgery Following Immunochemotherapy in Initially Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma—A Real-World Multicenter Study (RICE-Retro)

Shujie Huang, Hansheng Wu, Chao Cheng et al. · Frontiers in Immunology · 2022 · 32 citations · Full text

Medicine, Oncology, Surgery +17

Pan-mediastinal neoplasm diagnosis via nationwide federated learning: a multicentre cohort study

Ruijie Tang, Hengrui Liang, Yuchen Guo et al. · The Lancet Digital Health · 2023 · 16 citations · Full text

Medicine, Biomedical Informatics, Oncology +13